Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort …

KKW To, OTY Tsang, WS Leung, AR Tam… - The Lancet infectious …, 2020 - thelancet.com
Background Coronavirus disease 2019 (COVID-19) causes severe community and nosocomial
outbreaks. Comprehensive data for serial respiratory viral load and serum antibody …

Consistent detection of 2019 novel coronavirus in saliva

KKW To, OTY Tsang, CCY Yip, KH Chan… - Clinical Infectious …, 2020 - academic.oup.com
The 2019 novel coronavirus (2019-nCoV) was detected in the self-collected saliva of 91.7%
(11/12) of patients. Serial saliva viral load monitoring generally showed a declining trend. …

[HTML][HTML] A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

JFW Chan, S Yuan, KH Kok, KKW To, H Chu, J Yang… - The lancet, 2020 - thelancet.com
Background An ongoing outbreak of pneumonia associated with a novel coronavirus was
reported in Wuhan city, Hubei province, China. Affected patients were geographically linked …

[PDF][PDF] Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses

R Zhou, KKW To, YC Wong, L Liu, B Zhou, X Li… - Immunity, 2020 - cell.com
The SARS-CoV-2 pandemic has resulted in millions of infections, yet the role of host immune
responses in early COVID-19 pathogenesis remains unclear. By investigating 17 acute and …

Coronavirus disease 2019 (COVID-19) re-infection by a phylogenetically distinct severe acute respiratory syndrome coronavirus 2 strain confirmed by whole genome …

KKW To, IFN Hung, JD Ip, AWH Chu… - Clinical Infectious …, 2021 - academic.oup.com
Background Waning immunity occurs in patients who have recovered from Coronavirus
Disease 2019 (COVID-19). However, it remains unclear whether true re-infection occurs. …

[HTML][HTML] Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label …

IFN Hung, KC Lung, EYK Tso, R Liu, TWH Chung… - The Lancet, 2020 - thelancet.com
Background Effective antiviral therapy is important for tackling the coronavirus disease 2019
(COVID-19) pandemic. We assessed the efficacy and safety of combined interferon beta-1b, …

The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2

VCC Cheng, SC Wong, VWM Chuang, SYC So… - Journal of Infection, 2020 - Elsevier
Background Face mask usage by the healthy population in the community to reduce risk of
transmission of respiratory viruses remains controversial. We assessed the effect of …

Neutralization of severe acute respiratory syndrome coronavirus 2 omicron variant by sera from BNT162b2 or CoronaVac vaccine recipients

L Lu, BWY Mok, LL Chen, JMC Chan… - Clinical Infectious …, 2022 - academic.oup.com
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron
variant, designated as a variant of concern by the World Health Organization, carries …

[HTML][HTML] Attenuated replication and pathogenicity of SARS-CoV-2 B. 1.1. 529 Omicron

H Shuai, JFW Chan, B Hu, Y Chai, TTT Yuen, F Yin… - Nature, 2022 - nature.com
The Omicron (B.1.1.529) variant of SARS-CoV-2 emerged in November 2021 and is rapidly
spreading among the human population 1 . Although recent reports reveal that the Omicron …

[HTML][HTML] Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study

KKW To, VCC Cheng, JP Cai, KH Chan… - The Lancet …, 2020 - thelancet.com
Background The role of subclinical severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infections in perpetuating the COVID-19 pandemic is unknown because population …